News | AHA | November 21, 2019

Eko and Mayo Clinic Prove Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope

Study data presented at AHA show Eko DUO combined with advanced artificial intelligence algorithm effectively identifies low ejection fraction in patients

 

 EKO digital stethoscopes

November 21, 2019 — At the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying artificial intelligence (AI) and machine learning in the fight against heart disease, presented results in collaboration with Mayo Clinic demonstrating the use of the DUO digital stethoscope as a heart failure screening tool.

When tested on 100 patients, the DUO combined with an AI model was able to detect ejection fraction < 35 percent with an area under the curve (AUC) of 0.90, which is comparable to previously published research in Nature Medicine. These findings could help identify patients with a low ejection fraction during routine physical examinations, facilitating rapid clinical recognition of those requiring further testing. This marks the first time that a point of care device with a single lead ECG combined with an AI algorithm identified low ejection fraction in patients.

Ejection fraction is an important method of mortality prediction among cardiac patients and a low ejection fraction number suggests problems with the heart’s pumping function, and may be associated with heart failure. An estimated 6.2 million Americans suffer from heart failure, according to federal statistics. The American Heart Association predicts that more than eight million will have the condition by 2030.

“With treatment many people live well with heart failure, but detection is critical,” said Dr. Steve Pham, MD and vice president of clinical research and affairs at Eko, and co-author of the study. “Eko is working to change how auscultation is done, using cutting-edge machine learning and data science to predict, and prevent, the progression of chronic cardiovascular diseases. The results presented today validate Eko’s reinvention of the 200-year-old stethoscope and further cement its place in modern healthcare practices as a tool for detection and improved treatment.” 

The research was presented at the AHA event on Nov. 16. Eko is also exhibiting at this event, booth #1001. Eko will continue to collaborate with the Mayo Clinic to test the low ejection fraction screening algorithm, and intends to eventually submit for regulatory clearance. 

For more information: www.ekohealth.com

Links to the 2019 AHA late-breaking trials

 

Related Content

cardiac arrest cath lab
News | AHA | November 21, 2019
November 21, 2019 — People who experience cardiac arr...
heart disease
News | AHA | November 20, 2019
November 20, 2019 — Heart attack survivors may have an increased risk of developing cancer compared to people without
 Assorted pastries
News | AHA | November 20, 2019
November 20, 2019 — Ultra-processed foods, which account for more than half of an average American’s daily calories,
marijuana leaf
News | AHA | November 20, 2019
November 20, 2019 — Frequent cannabis (marijuana) use among young people was linked to an increased risk of...
In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff

In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff 

Feature | AHA | November 19, 2019
November 19, 2019 — After 12 years of collecting data, the results of the landmark ISCHEMIA (International Study of C
The American Heart Association, AHA, 2019 meeting late breaking trials and key studies on cardiovascular science.
Feature | AHA | November 19, 2019 | Dave Fornell, Editor
Here is a list of the key late-breaking clinical study presentations at the 2019 American Heart Association (AHA)...
 doctor heart failure patient from CorAssist
News | AHA | November 14, 2019
November 14, 2019 — More than a million Americans face a doubling in their risk of death during or while recovering f
 e-cigarette Image by Lindsay Fox from Pixabay

 Image courtesy Lindsay Fox from Pixabay

News | AHA | November 14, 2019
November 14, 2019 — A new study from researchers at the Sm...
 Cholesterol test prep blood draw needle stick from American Heart Association
News | AHA | November 14, 2019
November 14, 2019 — A large majority of patients with atherosclerotic cardiovascular disease (ASCVD) in the...
Overlay Init